BIOMARIN PHARMACEUTICAL earnings per share and revenue

4BMRN earnings per share for the last quarter are 0.49 EUR whereas the estimation was 0.48 EUR which accounts for 3.59% surprise. Company revenue for the same period amounts to 669.78 M EUR despite the estimated figure of 631.78 M EUR. Estimated earnings per share for the next quarter are 0.53 EUR, and revenue is expected to reach 681.25 M EUR. Also watch annual changes over time to get a bigger picture of 4BMRN earnings per share and revenue dynamics.